Literature DB >> 12111484

Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test.

S Savolainen1, H Hurskainen, L Paljärvi, I Alafuzoff, M Vapalahti.   

Abstract

BACKGROUND: Between 1993-1995, 51 patients under 75 years of age with clinical symptoms and CT-based diagnosis of normal pressure hydrocephalus were investigated prospectively in order to clarify the value of neuropsychological tests, clinical symptoms and signs and infusion test in the differential diagnosis and prediction of outcome in normal pressure hydrocephalus.
METHODS: Patients had a thorough neurological examination, and neuropsychological evaluation. A 24-hour intraventricular ICP-measurement, infusion test, neurophysiological investigations and MRI study were performed, and a cortical biopsy was obtained. The ICP measurement defined the need for a shunt. All 51 patients were re-examined three and twelve months later. The final follow-up was accomplished five years postoperatively.
FINDINGS: 25 of the patients needed a shunt operation. One year after a shunt placement 72% of these patients had a good recovery concerning activities of daily living, 58% benefited in their urinary incontinence and 57% walked better. During the 5 years of follow-up 8 patients with shunt and 9 without shunt had died. Positive effect of shunting remained. Only one neuropsychological test, recognition of words test, distinguishes the patients with the need for a shunt. Simple mini mental examination test was not different in those who improved. In the postoperative follow-up patients with shunt showed no change in neuropsychological tests even if they were subjectively better. The infusion test was of no value in diagnosing NPH. The 16 patients with Alzheimer's disease did worse after one year than those without pathological changes, but the mortality was not increased.
INTERPRETATION: Specific neuropsychological tests are of little value in diagnosing NPH. Mini-Mental status examination was neither of value in diagnosing NPH nor in prediction of the outcome. In this study the infusion test did not improve diagnostic accuracy of NPH, but shunt placement relieves urinary incontinence and walking disability in patients with increased ICP. The patients with positive Alzheimer diagnosis on biopsy did not improve.

Entities:  

Mesh:

Year:  2002        PMID: 12111484     DOI: 10.1007/s00701-002-0936-3

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  22 in total

Review 1.  [Bladder disorders in dementia and Alzheimer's disease. Rational diagnostic and therapeutic options].

Authors:  D Schultz-Lampel
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

Review 2.  A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus.

Authors:  Marta Picascia; Roberta Zangaglia; Sara Bernini; Brigida Minafra; Elena Sinforiani; Claudio Pacchetti
Journal:  Funct Neurol       Date:  2015 Oct-Dec

Review 3.  Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  John J Halperin; Roger Kurlan; Jason M Schwalb; Michael D Cusimano; Gary Gronseth; David Gloss
Journal:  Neurology       Date:  2015-12-08       Impact factor: 9.910

Review 4.  Natural history of idiopathic normal-pressure hydrocephalus.

Authors:  Ahmed K Toma; Simon Stapleton; Marios C Papadopoulos; Neil D Kitchen; Laurence D Watkins
Journal:  Neurosurg Rev       Date:  2011-05-19       Impact factor: 3.042

5.  Differential diagnosis of idiopathic normal pressure hydrocephalus from other dementias using diffusion tensor imaging.

Authors:  M J Kim; S W Seo; K M Lee; S T Kim; J I Lee; D H Nam; D L Na
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

6.  Postshunt cognitive and functional improvement in idiopathic normal pressure hydrocephalus.

Authors:  Heather Katzen; Lisa D Ravdin; Stephanie Assuras; Roberto Heros; Michael Kaplitt; Theodore H Schwartz; Matthew Fink; Bonnie E Levin; Norman R Relkin
Journal:  Neurosurgery       Date:  2011-02       Impact factor: 4.654

7.  Normal pressure hydrocephalus: how often does the diagnosis hold water?

Authors:  Bryan T Klassen; J Eric Ahlskog
Journal:  Neurology       Date:  2011-08-17       Impact factor: 9.910

Review 8.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

9.  Is a combination of Tc-SPECT or perfusion weighted magnetic resonance imaging with spinal tap test helpful in the diagnosis of normal pressure hydrocephalus?

Authors:  F Hertel; C Walter; M Schmitt; M Mörsdorf; W Jammers; H P Busch; M Bettag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

10.  Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus.

Authors:  Madoka Nakajima; Masakazu Miyajima; Ikuko Ogino; Maki Watanabe; Haruko Miyata; Kostadin L Karagiozov; Hajime Arai; Yoshiaki Hagiwara; Tatsuya Segawa; Kyoko Kobayashi; Yasuhiro Hashimoto
Journal:  Acta Neurochir (Wien)       Date:  2011-02-19       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.